FFCP PHASE1:Hg19::chr5:133880112..133880133,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=23338 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=22984 | |||
|TSSclassifier=strong | |||
|UniProt= | |||
|association_with_transcript=0bp_to_ENST00000453515_5end | |||
|coexpression_cluster_id=C442 | |||
|description=CAGE_peak_20_at_PHF15_5end | |||
|id=chr5:133880112..133880133,+ | |||
|ontology_enrichment_celltype=CL:0000945!7.67e-48!24;CL:0000826!7.67e-48!24;CL:0000236!1.27e-27!14;CL:0000542!2.57e-23!53;CL:0000051!2.57e-23!53;CL:0000838!1.51e-20!52;CL:0000988!1.94e-10!182;CL:0000037!4.64e-10!172;CL:0000566!4.64e-10!172;CL:0002087!6.67e-10!119;CL:0002032!2.67e-08!165;CL:0000837!2.67e-08!165;CL:0000738!6.00e-08!140;CL:0000819!6.59e-08!1;CL:0001024!2.21e-07!1;CL:0002031!6.45e-07!124 | |||
|ontology_enrichment_celltype_v019=CL:0000945;4.63e-37;24!CL:0000785;2.16e-26;1!CL:0000819;2.16e-26;1!CL:0000236;9.08e-18;13!CL:0000542;3.76e-16;53 | |||
|ontology_enrichment_celltype_v019_2=CL:0000945,5.25e-37,24;CL:0000826,5.25e-37,24;CL:0000819,2.16e-26,1;CL:0000542,7.43e-23,53;CL:0000051,7.43e-23,53;CL:0000838,3.16e-17,52;CL:0000236,1.48e-16,14;CL:0000785,6.43e-14,2;CL:0000955,6.43e-14,2;CL:0000818,6.43e-14,2;CL:0000954,6.43e-14,2;CL:0000816,6.43e-14,2;CL:0002087,1.79e-10,115;CL:0000817,1.01e-09,3;CL:0000738,7.34e-09,136;CL:0002032,1.77e-07,161;CL:0000837,1.77e-07,161;CL:0002031,1.91e-07,120;CL:0000037,3.66e-07,168;CL:0000988,8.58e-07,177 | |||
|ontology_enrichment_development_v019=CL:0000051;3.76e-16;53!CL:0000954;6.43e-14;2 | |||
|ontology_enrichment_disease=DOID:0060058!1.47e-10!10;DOID:0060073!6.59e-08!1;DOID:8675!6.59e-08!1;DOID:12603!8.00e-08!1;DOID:9119!2.07e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:0060058;4.30e-40;10!DOID:0060073;2.16e-26;1!DOID:8675;2.16e-26;1!DOID:12603;5.22e-26;1!DOID:2531;2.16e-07;51!DOID:0060083;2.16e-07;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060058,5.25e-40,10;DOID:0060073,2.16e-26,1;DOID:8675,2.16e-26,1;DOID:12603,4.61e-26,1;DOID:2531,1.89e-12,51;DOID:0060083,1.89e-12,51 | |||
|ontology_enrichment_uberon=UBERON:0004177!5.39e-14!7;UBERON:0002106!3.24e-09!3;UBERON:0004854!3.24e-09!3;UBERON:0009034!3.24e-09!3;UBERON:0002095!3.24e-09!3;UBERON:0004782!3.24e-09!3;UBERON:0003281!3.24e-09!3;UBERON:0009664!3.24e-09!3;UBERON:0002296!3.24e-09!3;UBERON:0005602!3.24e-09!3;UBERON:0001179!3.24e-09!3;UBERON:0006293!3.24e-09!3;UBERON:0001154!1.51e-07!1;UBERON:0001153!1.51e-07!1;UBERON:0002372!1.61e-07!1;UBERON:0001961!1.61e-07!1;UBERON:0001744!1.61e-07!1;UBERON:0001735!1.61e-07!1;UBERON:0002370!8.69e-07!4;UBERON:0005058!8.69e-07!4;UBERON:0009113!8.69e-07!4;UBERON:0003295!8.69e-07!4;UBERON:0005562!8.69e-07!4 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0764134057479513,0,0.0787107813136792,0,0,0,0,0,0,2.24654881682875,2.27470771979874,0.293600439334847,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.889509253863555,0.426730222566507,0.800791974072025,1.14950487990897,0,0.954053754535364,0,1.76171156811282,0.382273228125229,0,0.560508562981536,2.63384084775077,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0945348171640679,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206768026122887,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.41544127663434,0,0,0,0,0,0,0,0,0.228234679033192,0,0,0,0,0,0,0,0,0,0,0.19538809540204,0,0,0,0.33307196799782,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.552567831062295,0,0,0.246169610922139,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0884575645033392,0,0,0.123563938946503,0,0,0,0,6.38591762254831,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.225980740780532,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.87170393523584,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.23658523500376,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.563903507879121,0.386747327841463,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0645889098360061,0.248298857183432,0,0,0,0,0,0.471464371102113,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p20@PHF15 | |||
}} |
Revision as of 07:28, 22 January 2014
Short description: | p20@PHF15 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_20_at_PHF15_5end |
Coexpression cluster: | C442_diffuse_xeroderma_lymphoma_Burkitt_plasma_b_lymphangiectasia |
Association with transcript: | 0bp_to_ENST00000453515_5end |
EntrezGene: | PHF15 |
HGNC: | 22984 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 5.25e-37 | 24 |
pro-B cell | 5.25e-37 | 24 |
B-1 B cell | 2.16e-26 | 1 |
lymphocyte | 7.43e-23 | 53 |
common lymphoid progenitor | 7.43e-23 | 53 |
lymphoid lineage restricted progenitor cell | 3.16e-17 | 52 |
B cell | 1.48e-16 | 14 |
mature B cell | 6.43e-14 | 2 |
pre-B-II cell | 6.43e-14 | 2 |
transitional stage B cell | 6.43e-14 | 2 |
small pre-B-II cell | 6.43e-14 | 2 |
immature B cell | 6.43e-14 | 2 |
nongranular leukocyte | 1.79e-10 | 115 |
precursor B cell | 1.01e-09 | 3 |
leukocyte | 7.34e-09 | 136 |
hematopoietic oligopotent progenitor cell | 1.77e-07 | 161 |
hematopoietic multipotent progenitor cell | 1.77e-07 | 161 |
hematopoietic lineage restricted progenitor cell | 1.91e-07 | 120 |
hematopoietic stem cell | 3.66e-07 | 168 |
hematopoietic cell | 8.58e-07 | 177 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 5.25e-40 | 10 |
lymphatic system cancer | 2.16e-26 | 1 |
lymphosarcoma | 2.16e-26 | 1 |
acute leukemia | 4.61e-26 | 1 |
hematologic cancer | 1.89e-12 | 51 |
immune system cancer | 1.89e-12 | 51 |